Tag: Plasma-derived Therapeutics
Evolve Biologics Creating 300 Jobs In Texas At First Manufacturing Facility
The $200 million facility in Sachse, TX will be first to use Evolve’s innovative PlasmaCap EBA® technology to produce plasma-derived therapeutics.
2022 Deal Of The Year: Impact Awards
The 2022 Deal of the Year Impact Awards recognize project investments that will have significant impact in their new or expanded locations, focusing on a specific aspect of the project.
2022 Deal Of The Year: Platinum Award
Here are this year’s Deal of the Year award winners, starting with Platinum Winner Empire State Development, for Micron Technology's $100B investment in New York State.